Asarfi Hospital Share Price | Asarfi Hospital Stock Screener
ASARFI
Hospitals
Track Asarfi Hospital share price live with TickJournal's free stock screener.
Check ASARFI price range for the annual price range and momentum.
Use the Asarfi Hospital stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Asarfi Hospital Market Cap
₹383.70 Cr.
ASARFI P/E Ratio (TTM)
22.30
Asarfi Hospital P/B Ratio
3.81
EPS (TTM)
₹8.47
Dividend Yield
-
Debt to Equity
0.53
ASARFI 52 Week High
-
Asarfi Hospital 52 Week Low
-
Operating Margin
17.00%
Profit Margin
8.70%
ASARFI Revenue (TTM)
₹46.00
EBITDA
₹8.00
Net Income
₹4.00
Total Assets
₹193.00
Total Equity
₹98.00
Asarfi Hospital Share Price Chart
Screen Asarfi Hospital share price with an interactive chart. Analyse ASARFI price trends and volatility across different timeframes.
Asarfi Hospital Company Profile - Fundamental Screener
Screen Asarfi Hospital company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ASARFI shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE0DN001027
Asarfi Hospital Balance Sheet Screener
Screen ASARFI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 |
|---|---|---|---|
| Assets | |||
| Total Assets | 193 | 164 | 154 |
| Current Assets | 71 | 59 | 46 |
| Fixed Assets | 110 | 102 | 94 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 46 | 42 | 39 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 98 | 81 | 70 |
| Share Capital | 20 | 20 | 20 |
| Reserves & Surplus | 78 | 61 | 51 |
Asarfi Hospital Income Statement Screener - Profit & Revenue Analysis
Screen Asarfi Hospital income statement and profit fundamentals.
Analyze ASARFI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Asarfi Hospital share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46 | 48 | 46 | 37 | 39 | 24 | 24 | 32 | 34 | 21 |
| Expenses | 38 | 36 | 36 | 29 | 29 | 20 | 18 | 24 | 26 | 16 |
| EBITDA | 8 | 12 | 10 | 8 | 10 | 4 | 5 | 8 | 8 | 5 |
| Operating Profit % | 17.00% | 22.00% | 20.00% | 20.00% | 18.00% | 16.00% | 21.00% | 22.00% | 21.00% | 20.00% |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 5 | 7 | 6 | 4 | 5 | -1 | 2 | 4 | 4 | 1 |
| Tax | 1 | 2 | 2 | 1 | 2 | -1 | 0 | 1 | 1 | 1 |
| Net Profit | 4 | 5 | 4 | 3 | 4 | 0 | 2 | 3 | 3 | 0 |
| EPS | 1.99 | 2.76 | 2.13 | 1.59 | 1.82 | -0.18 | 0.74 | 1.45 | 1.36 | -0.03 |
Asarfi Hospital Cash Flow Screener - Liquidity Fundamentals
Screen ASARFI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | -4 | 26 |
| Investing Activities | -7 | -63 |
| Financing Activities | 13 | 36 |
| Net Cash Flow | 1 | -1 |
Asarfi Hospital Shareholding Pattern Screener
See Asarfi Hospital shareholding pattern with promoter, FII, and DII holdings.
Check Asarfi Hospital promoter holding and ownership changes for ASARFI on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Sept | 2024-Mar | 2023-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% |
| FII Holding | 0.00% | 0.00% | 0.05% | 0.10% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 2.40% | 1.98% | 2.19% | 3.18% | 2.92% | 1.95% | 2.33% | 3.25% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.63% | 31.72% | 30.89% | 29.89% | 30.86% | 32.99% | 31.63% | 27.40% |
| Other Holding | 5.79% | 5.13% | 5.70% | 5.66% | 5.05% | 3.89% | 4.87% | 8.18% |
| Shareholder Count | 1,316 | 1,225 | 1,167 | 1,176 | 1,262 | 1,284 | 1,261 | 706 |
Asarfi Hospital Share Dividend Screener - Share Yield Analysis
Check Asarfi Hospital dividend history with payout and yield data.
View Asarfi Hospital dividend details including ex-dates and amounts for ASARFI stock.
Asarfi Hospital Stock Index Membership
See which indices include Asarfi Hospital stock.
Check ASARFI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Asarfi Hospital Market Events Screener - Corporate Actions
Get Asarfi Hospital corporate actions including splits, bonuses, and buybacks.
Check Asarfi Hospital stock events that may affect ASARFI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 16.21% | ||
| Annual General Meeting | NA | 0.43% | ||
| 2026-05-11 | 2026-05-11 | Quarterly Result Announcement | NA | 17.04% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | 1.50% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -2.14% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | 5.12% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | 1.29% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 6.02% |
| 2024-01-30 | 2024-01-30 | Extraordinary General Meeting | NA | 13.33% |
Asarfi Hospital Competitors Screener - Peer Comparison
Screen ASARFI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 116,214 | 62.54 | 21,994 | 14.76% | 1,505 | 64.49 |
| Max Healthcare Institute | 102,189 | 72.00 | 7,184 | 28.68% | 1,076 | 63.41 |
| Fortis Healthcare | 72,752 | 74.73 | 7,850 | 13.25% | 809 | 62.03 |
| Aster DM Healthcare | 39,048 | 90.42 | 4,643 | 8.32% | 384 | 66.43 |
| Narayana Hrudayalaya | 37,625 | 47.59 | 5,575 | 12.29% | 790 | 56.40 |
| Global Health | 33,397 | 63.42 | 3,771 | 12.59% | 481 | 67.36 |
| Krishna Institute of Medical Sciences | 30,477 | 98.51 | 3,067 | 21.98% | 415 | 65.47 |
| Dr. Agarwal's Health Care | 14,260 | 87.99 | 1,757 | 27.64% | 110 | 52.19 |
| Rainbow Childrens Medicare | 13,570 | 51.41 | 1,567 | 17.46% | 244 | 65.23 |
| Park Medi World | 10,559 | 39.26 | 1,679 | 17.77% | 272 | 60.62 |
Asarfi Hospital Company Announcements - News Screener
Screen ASARFI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-16 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-16 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-16 | Submission Of Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-16 | Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th May 2026 And Submission Of Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended 31St March 2026 Pursuant To Regulation 33 Of SEBI (LODR) Regulations 2015 | - |
| 2026-05-04 | Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-09 | Submission Of Unaudited Financial Results For The Quarter Ended 31St December 2025 | - |
| 2026-02-09 | Board Meeting Outcome for Outcome Of Board Meeting Held On 09 February 2026 And Submission Of Unaudited Financial Results For The Quarter Ended 31St December 2025. | - |
| 2026-02-02 | Board Meeting Intimation for Consider And Adopt The Unaudited Financial Results For The Quarter Ended 31St December 2025 Along With The Limited Review Report Issued By M/S R. K. Thakkar & Co. Chartered Accountants. | - |
| 2025-12-27 | Closure of Trading Window | - |
| 2025-12-05 | Update Of Group Meeting Of Analyst/Institutional Investor Meetings Held On December 4 2025 | - |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-22 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |